DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mibampator
Mibampator
Effect of Dextromethorphan-Quinidine on Agitation in Patients with Alzheimer Disease Dementia a Randomized Clinical Trial
WO 2016/001643 Al 7 January 2016 (07.01.2016) P O P C T
(12) United States Patent (10) Patent No.: US 9,605,007 B2 Brodney Et Al
Drug Delivery System for Use in the Treatment Or Diagnosis of Neurological Disorders
(Jacques JENNIGES).Pdf
Effect of Dextromethorphan-Quinidine on Agitation in Patients with Alzheimer Disease Dementia a Randomized Clinical Trial
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
FACULTE DES SCIENCES Département De Chimie
Dementia-Related Agitation: a Review of Non-Pharmacological Interventions and Analysis of Risks and Benefits of Pharmacotherapy
Membrane Transporter/Ion Channel
Treatment of Adults with Clinical Alzheimer's-Type Dementia (CATD)
Supplementary Material Emethods1. Search Strategy Emethods2. Data
(12) United States Patent (10) Patent No.: US 8,916,564 B2 Pettersson Et Al
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Pharmacotherapy of Behavioral and Psychological
Auxiliary Proteins Are the Predominant Determinants of Differential Efficacy of Clinical Candidates Acting As AMPA Receptor Positive Allosteric Modulators
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Randomized Controlled Trial of Mibampator for Behavioral and Psychological Symptoms of Dementia: Comments on the Trial and Thoughts for Future Studies
Top View
CURRICULUM VITAE JEFFREY L. CUMMINGS, M.D., Sc.D
Bioactive Compound Library Plus (96-Well)
Poster Session II Cntnap2a and 2B Knockouts
INN-Nimet 1 27.11.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Drug Repurposing Compound Library Plus (96-Well)
Download (1MB)
Neurological Disease
Suffixes Used in the Selection of INN and Their Published INN May 2018
Membrane Transporter/Ion Channel Compound Library (96-Well)
Neuronal Signaling
Keyword Index
(12) United States Patent (10) Patent No.: US 9,045,498 B2 Brodney Et Al
Medication Development for Agitation and Aggression in Alzheimer Disease: Review and Discussion of Recent Randomized Clinical Trial Design
Ionotropic Glutamate Receptors
Curegrin Research Audit June 5, 2021
Q1 Top 3 Clinical Journals: Annual Review of Clinical Psychology, Clinical Psychology Review, Journal of Consulting and Clinical Psychology
Strictly Regulated Agonist-Dependent Activation of AMPA-R Is The
A Randomized Clinical Trial
Effect of Dextromethorphan-Quinidine on Agitation in Patients with Alzheimer Disease Dementia a Randomized Clinical Trial
Ep 3160590 B1
118554 1 Auxiliary Proteins Are the Predominant Determinants Of